{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:51:41Z","timestamp":1781844701835,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China Children\u2019s Growth and Development Academic Exchange Special Fund, Pediatric Endocrinology Young and Middle-aged Physicians Growth Research Fund","award":["Z-2019-41-2201"],"award-info":[{"award-number":["Z-2019-41-2201"]}]},{"name":"Science and Technology Planning Project of Huizhou, China","award":["2023CZ010074"],"award-info":[{"award-number":["2023CZ010074"]}]},{"name":"Science and Technology Planning Project of Huizhou, China","award":["2022CZ010007"],"award-info":[{"award-number":["2022CZ010007"]}]},{"name":"Science and Technology Planning Project of Huizhou, China","award":["2023CZ010042"],"award-info":[{"award-number":["2023CZ010042"]}]},{"name":"Science and Technology Planning Project of Huizhou, China","award":["2019C0603010"],"award-info":[{"award-number":["2019C0603010"]}]},{"name":"Medical Science and Technology Research Foundation of Guangdong Province, China","award":["A2022443"],"award-info":[{"award-number":["A2022443"]}]},{"name":"Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties","award":["SZGSP012"],"award-info":[{"award-number":["SZGSP012"]}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Fundamental Research Program","doi-asserted-by":"crossref","award":["KCXFZ20201221173400002"],"award-info":[{"award-number":["KCXFZ20201221173400002"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM202411011"],"award-info":[{"award-number":["SZSM202411011"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-06955-8","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T14:05:14Z","timestamp":1777730714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Osteoporosis in children and adolescents with transfusion-dependent thalassemia and the diagnostic value of different indicators"],"prefix":"10.1186","volume":"26","author":[{"given":"Xinxia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuhua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chushan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"6955_CR1","unstructured":"Langer AL et al. Beta-Thalassemia. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, editors. GeneReviews((R)). Seattle (WA)2021."},{"issue":"Suppl 1","key":"6955_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/ijlh.13885","volume":"44","author":"CL Harteveld","year":"2022","unstructured":"Harteveld CL, Achour A, Arkesteijn SJG, Ter Huurne J, Verschuren M, Bhagwandien-Bisoen S, et al. The hemoglobinopathies, molecular disease mechanisms and diagnostics. Int J Lab Hematol. 2022;44(Suppl 1):28\u201336.","journal-title":"Int J Lab Hematol"},{"key":"6955_CR3","doi-asserted-by":"publisher","first-page":"e732","DOI":"10.1097\/HS9.0000000000000732","volume":"6","author":"D Farmakis","year":"2022","unstructured":"Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A. 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia. Hemasphere. 2022;6:e732.","journal-title":"Hemasphere"},{"key":"6955_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1172-5-13","volume":"5","author":"CL Harteveld","year":"2010","unstructured":"Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet J Rare Dis. 2010;5:13.","journal-title":"Orphanet J Rare Dis"},{"key":"6955_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/GIM.0b013e3181fcb468","volume":"13","author":"R Galanello","year":"2011","unstructured":"Galanello R, Cao A. Gene test review. Alpha-thalassemia. Genet Med. 2011;13:83\u20138.","journal-title":"Genet Med"},{"key":"6955_CR6","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/S0140-6736(22)00536-0","volume":"399","author":"A Kattamis","year":"2022","unstructured":"Kattamis A, Kwiatkowski JL, Aydinok Y, Thalassaemia. Lancet. 2022;399:2310\u201324.","journal-title":"Lancet"},{"key":"6955_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ped4.12154","volume":"4","author":"X Xu","year":"2020","unstructured":"Xu X, Wu X. Epidemiology and treatment of beta thalassemia major in China. Pediatr Investig. 2020;4:43\u20137.","journal-title":"Pediatr Investig"},{"key":"6955_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12185-018-2411-9","volume":"108","author":"C Asadov","year":"2018","unstructured":"Asadov C, Alimirzoeva Z, Mammadova T, Aliyeva G, Gafarova S, Mammadov J. beta-Thalassemia intermedia: a comprehensive overview and novel approaches. Int J Hematol. 2018;108:5\u201321.","journal-title":"Int J Hematol"},{"key":"6955_CR9","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","volume":"115","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010;115:1886\u201392.","journal-title":"Blood"},{"key":"6955_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12020-019-02159-6","volume":"69","author":"M Karimi","year":"2020","unstructured":"Karimi M, Zarei T, Haghpanah S, Azarkeivan A, Kattamis C, Ladis V, et al. Evaluation of endocrine complications in beta-thalassemia intermedia (beta-TI): a cross-sectional multicenter study. Endocrine. 2020;69:220\u20137.","journal-title":"Endocrine"},{"key":"6955_CR11","doi-asserted-by":"publisher","first-page":"e70095","DOI":"10.1002\/hem3.70095","volume":"9","author":"KM Musallam","year":"2025","unstructured":"Musallam KM, Cappellini MD, Porter JB, Farmakis D, Eleftheriou A, Angastiniotis M, et al. TIF Guidelines for the Management of Transfusion-Dependent beta-Thalassemia. Hemasphere. 2025;9:e70095.","journal-title":"Hemasphere"},{"key":"6955_CR12","unstructured":"Taher AT, Farmakis D, Porter JB, Cappellini MD, Musallam KM. Guidelines for the Management of Transfusion-Dependent \u03b2\u2010Thalassaemia. 5th ed. Thalassaemia International Federation; 2025."},{"key":"6955_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4274\/jcrpe.galenos.2018.2018.0074","volume":"11","author":"A Gaudio","year":"2019","unstructured":"Gaudio A, Morabito N, Catalano A, Rapisarda R, Xourafa A, Lasco A. Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience. J Clin Res Pediatr Endocrinol. 2019;11:110\u20137.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"6955_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jocd.2020.08.001","volume":"24","author":"V Ekbote","year":"2021","unstructured":"Ekbote V, Khadilkar A, Chauthmal S, Padidela R, Khadilkar S, Mughal Z, et al. Assessment of Bone Density by DXA in Poorly Controlled Children With beta-Thalassemia: Correction for Hepatic Iron Overload by Manual Analysis. J Clin Densitom. 2021;24:383\u20137.","journal-title":"J Clin Densitom"},{"key":"6955_CR15","doi-asserted-by":"crossref","unstructured":"Lems WF, Ward KA, Lewiecki EM, Richmond B, Probyn L, Ali DS et al. Making VFA Part of Standard Clinical DXA Assessment for Osteoporosis Care: Recommendations From the International Working Group on DXA Best Practices. Mayo Clin Proc. 2025;100:2186\u2009\u2013\u2009205.","DOI":"10.1016\/j.mayocp.2025.08.005"},{"key":"6955_CR16","first-page":"Cd010429","volume":"5","author":"A Bhardwaj","year":"2023","unstructured":"Bhardwaj A, Swe KMM, Sinha NK. Treatment for osteoporosis in people with beta-thalassaemia. Cochrane Database Syst Rev. 2023;5:Cd010429.","journal-title":"Cochrane Database Syst Rev"},{"key":"6955_CR17","doi-asserted-by":"crossref","unstructured":"Cappellini MD, Farmakis D, Porter J, Taher A. 2021 Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT). 4th Edition. Nicosia: Thalassaemia International Federation; 2021.","DOI":"10.1097\/HS9.0000000000000732"},{"key":"6955_CR18","first-page":"163","volume":"25","author":"S Chaopeng","year":"2019","unstructured":"Chaopeng S, Qun L, Changlin W. Chinese expert consensus on clinical transfusion of transfusion-dependent thalassemia (TDT) patients. J Clin Blood Transfus Lab Res. 2019;25:163\u20139.","journal-title":"J Clin Blood Transfus Lab Res"},{"key":"6955_CR19","unstructured":"[Chinese guideline for diagnosis and treatment of transfusion dependent \u03b2-thalassemia. (2022)]. Zhonghua Xue Ye Xue Za Zhi. 2022;43:889\u2009\u2013\u200996."},{"key":"6955_CR20","first-page":"595","volume":"37","author":"L Wang","year":"2022","unstructured":"Wang L, Su Z, Jiao Y. [Diagnosis and treatment of osteoporosis in children]. Chin J Pract Ped. 2022;37:595\u2013600.","journal-title":"Chin J Pract Ped"},{"key":"6955_CR21","doi-asserted-by":"crossref","unstructured":"Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR et al. Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. J Clin Densitom. 2019;22:453\u2009\u2013\u200971.","DOI":"10.1016\/j.jocd.2019.07.001"},{"key":"6955_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Min Res. 1993;8:1137\u201348.","journal-title":"J Bone Min Res"},{"key":"6955_CR23","doi-asserted-by":"crossref","unstructured":"Bachrach LK, Gordon CM, Section On E. Bone Densitometry in Children and Adolescents. Pediatrics. 2016;138.","DOI":"10.1542\/peds.2016-2398"},{"key":"6955_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","volume":"17","author":"NJ Crabtree","year":"2014","unstructured":"Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, et al. Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom. 2014;17:225\u201342.","journal-title":"J Clin Densitom"},{"key":"6955_CR25","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/pbc.22956","volume":"57","author":"SR Rose","year":"2011","unstructured":"Rose SR, Rutter MM, Mueller R, Harris M, Hamon B, Bulluck AF, et al. Bone mineral density is normal in children with Fanconi anemia. Pediatr Blood Cancer. 2011;57:1034\u20138.","journal-title":"Pediatr Blood Cancer"},{"key":"6955_CR26","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/jbmr.392","volume":"26","author":"CM Gordon","year":"2011","unstructured":"Gordon CM, Gordon LB, Snyder BD, Nazarian A, Quinn N, Huh S, et al. Hutchinson-Gilford progeria is a skeletal dysplasia. J Bone Min Res. 2011;26:1670\u20139.","journal-title":"J Bone Min Res"},{"key":"6955_CR27","doi-asserted-by":"publisher","first-page":"e014542","DOI":"10.1136\/bmjopen-2016-014542","volume":"7","author":"J Liu","year":"2017","unstructured":"Liu J, Wang L, Sun J, Liu G, Yan W, Xi B, et al. Bone mineral density reference standards for Chinese children aged 3\u201318: cross-sectional results of the 2013\u20132015 China Child and Adolescent Cardiovascular Health (CCACH) Study. BMJ Open. 2017;7:e014542.","journal-title":"BMJ Open"},{"key":"6955_CR28","first-page":"487","volume":"47","author":"H Li","year":"2009","unstructured":"Li H, Ji CY, Zong XN, Zhang YQ. [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years]. Zhonghua Er Ke Za Zhi. 2009;47:487\u201392.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"6955_CR29","first-page":"493","volume":"47","author":"H Li","year":"2009","unstructured":"Li H, Ji CY, Zong XN, Zhang YQ. [Body mass index growth curves for Chinese children and adolescents aged 0 to 18 years]. Zhonghua Er Ke Za Zhi. 2009;47:493\u20138.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"6955_CR30","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.eprac.2022.04.004","volume":"28","author":"B Cao","year":"2022","unstructured":"Cao B, Peng Y, Song W, Peng X, Hu L, Liu Z, et al. Pediatric Continuous Reference Intervals of Serum Insulin-like Growth Factor 1 Levels in a Healthy Chinese Children Population - Based on PRINCE Study. Endocr Pract. 2022;28:696\u2013702.","journal-title":"Endocr Pract"},{"key":"6955_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cca.2020.03.028","volume":"506","author":"J Wang","year":"2020","unstructured":"Wang J, Jiang L, Zhang X, Gong S, Chen M, Hu X, et al. Age-specific reference intervals for anti-Mullerian hormone in Chinese boys: A population-based study. Clin Chim Acta. 2020;506:154\u20139.","journal-title":"Clin Chim Acta"},{"key":"6955_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/00045632211002879","volume":"58","author":"J Wang","year":"2021","unstructured":"Wang J, Yao T, Zhang X, Chen Q, Gong S, Jiang L, et al. Age-specific reference intervals of serum anti-Mullerian hormone in Chinese girls. Ann Clin Biochem. 2021;58:350\u20137.","journal-title":"Ann Clin Biochem"},{"key":"6955_CR33","doi-asserted-by":"publisher","first-page":"115879","DOI":"10.1016\/j.bone.2021.115879","volume":"146","author":"SS Diemar","year":"2021","unstructured":"Diemar SS, Lylloff L, Ronne MS, Mollehave LT, Heidemann M, Thuesen BH, et al. Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (beta-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP). Bone. 2021;146:115879.","journal-title":"Bone"},{"key":"6955_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jocd.2013.11.003","volume":"17","author":"SH Chou","year":"2014","unstructured":"Chou SH, Vokes TJ, Ma SL, Costello M, Rosen HR, Schousboe JT. Simplified criteria for selecting patients for vertebral fracture assessment. J Clin Densitom. 2014;17:386\u201391.","journal-title":"J Clin Densitom"},{"key":"6955_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/03630269.2014.905792","volume":"38","author":"P Tzoulis","year":"2014","unstructured":"Tzoulis P, Ang AL, Shah FT, Berovic M, Prescott E, Jones R, et al. Prevalence of low bone mass and vitamin D deficiency in beta-thalassemia major. Hemoglobin. 2014;38:173\u20138.","journal-title":"Hemoglobin"},{"key":"6955_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5372\/1905-7415.0902.383","volume":"9","author":"C Nakhakes","year":"2015","unstructured":"Nakhakes C, Jaruluxananan S, Saengsuda Y, Saengsuda S. Risk factors for osteoporosis and the relationship between osteoporosis and hemoglobin level in adult patients with thalassemia in Rajavithi hospital. Asian Biomed. 2015;9:169\u201374.","journal-title":"Asian Biomed"},{"key":"6955_CR37","doi-asserted-by":"publisher","first-page":"4634709","DOI":"10.1155\/2020\/4634709","volume":"2020","author":"N Teawtrakul","year":"2020","unstructured":"Teawtrakul N, Chukanhom S, Charoensri S, Somboonporn C, Pongchaiyakul C. The Trabecular Bone Score as a Predictor for Thalassemia-Induced Vertebral Fractures in Northeastern Thailand. Anemia. 2020;2020:4634709.","journal-title":"Anemia"},{"key":"6955_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11657-020-00811-7","volume":"15","author":"M Bordbar","year":"2020","unstructured":"Bordbar M, Omrani GR, Haghpanah S, Saki F, Karimi M, Zekavat O. Bone mineral density in transfusion-dependent thalassemia patients and its associated factors in Southern Iran. Arch Osteoporos. 2020;15:148.","journal-title":"Arch Osteoporos"},{"key":"6955_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11657-021-01026-0","volume":"16","author":"N Charoenngam","year":"2021","unstructured":"Charoenngam N, Rittiphairoj T, Ponvilawan B. Fracture prevalence in thalassemia: a systematic review and meta-analysis. Arch Osteoporos. 2021;16:171.","journal-title":"Arch Osteoporos"},{"key":"6955_CR40","first-page":"e56012","volume":"16","author":"RP Shamoon","year":"2024","unstructured":"Shamoon RP, Yassin AK, Omar N, Saeed MD, Akram R, Othman NN. Magnitude of Bone Disease in Transfusion-Dependent and Non-Transfusion-Dependent beta-Thalassemia Patients. Cureus. 2024;16:e56012.","journal-title":"Cureus"},{"key":"6955_CR41","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s13312-022-2663-6","volume":"59","author":"K Handattu","year":"2022","unstructured":"Handattu K, Aroor S, Kini P, Ramesh Bhat Y, Shivakumar G, Shastry P, et al. Metabolic Bone Disease in Children With Transfusion-Dependent Thalassemia. Indian Pediatr. 2022;59:920\u20133.","journal-title":"Indian Pediatr"},{"key":"6955_CR42","doi-asserted-by":"crossref","unstructured":"Ong ZM, Foong WC, Yeoh SL, Yeoh AAC. Osteoporosis-osteopenia syndrome in children with transfusion dependent thalassemia. BMC Proc. 2015;9:A17.","DOI":"10.1186\/1753-6561-9-S7-A17"},{"key":"6955_CR43","doi-asserted-by":"publisher","first-page":"16413","DOI":"10.1038\/s41598-023-43633-6","volume":"13","author":"S Thavonlun","year":"2023","unstructured":"Thavonlun S, Houngngam N, Kingpetch K, Numkarunarunrote N, Santisitthanon P, Buranasupkajorn P, et al. Association of osteoporosis and sarcopenia with fracture risk in transfusion-dependent thalassemia. Sci Rep. 2023;13:16413.","journal-title":"Sci Rep"},{"key":"6955_CR44","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00431-022-04455-2","volume":"181","author":"S Ciancia","year":"2022","unstructured":"Ciancia S, van Rijn RR, Hogler W, Appelman-Dijkstra NM, Boot AM, Sas TCJ, et al. Osteoporosis in children and adolescents: when to suspect and how to diagnose it. Eur J Pediatr. 2022;181:2549\u201361.","journal-title":"Eur J Pediatr"},{"key":"6955_CR45","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1210\/er.2015-1105","volume":"37","author":"P Wong","year":"2016","unstructured":"Wong P, Fuller PJ, Gillespie MT, Milat F. Bone Disease in Thalassemia: A Molecular and Clinical Overview. Endocr Rev. 2016;37:320\u201346.","journal-title":"Endocr Rev"},{"issue":"7","key":"6955_CR46","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jpeds.2010.04.064","volume":"157","author":"EB Fung","year":"2010","unstructured":"Fung EB, Xu Y, Kwiatkowski JL, Vogiatzi MG, Neufeld E, Olivieri N, et al. Relationship between chronic transfusion therapy and body composition in subjects with thalassemia. J Pediatr. 2010;157(7):641\u20137.","journal-title":"J Pediatr"},{"key":"6955_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-145-4-200608150-00005","volume":"145","author":"AG Uitterlinden","year":"2006","unstructured":"Uitterlinden AG, Ralston SH, Brandi ML, Carey AH, Grinberg D, Langdahl BL, et al. The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med. 2006;145:255\u201364.","journal-title":"Ann Intern Med"},{"key":"6955_CR48","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/jbmr.3026","volume":"32","author":"K Steer","year":"2017","unstructured":"Steer K, Stavnichuk M, Morris M, Komarova SV. Bone Health in Patients With Hematopoietic Disorders of Bone Marrow Origin: Systematic Review and Meta- Analysis. J Bone Min Res. 2017;32:731\u201342.","journal-title":"J Bone Min Res"},{"key":"6955_CR49","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3324\/haematol.2014.104463","volume":"99","author":"F Rossi","year":"2014","unstructured":"Rossi F, Perrotta S, Bellini G, Luongo L, Tortora C, Siniscalco D, et al. Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels. Haematologica. 2014;99:1876\u201384.","journal-title":"Haematologica"},{"key":"6955_CR50","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2141.2009.07793.x","volume":"146","author":"MG Vogiatzi","year":"2009","unstructured":"Vogiatzi MG, Macklin EA, Trachtenberg FL, Fung EB, Cheung AM, Vichinsky E, et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol. 2009;146:546\u201356.","journal-title":"Br J Haematol"},{"key":"6955_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13052-022-01290-x","volume":"48","author":"T Celik","year":"2022","unstructured":"Celik T, Sangun O, Unal S, Balci A, Motor S. Assessment of biochemical bone markers of osteoporosis in children with thalassemia major. Ital J Pediatr. 2022;48:105.","journal-title":"Ital J Pediatr"},{"key":"6955_CR52","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1002\/edm2.340","volume":"5","author":"SLK Lee","year":"2022","unstructured":"Lee SLK, Wong RSM, Li CK, Leung WK. Prevalence and risk factors of fractures in transfusion dependent thalassemia - A Hong Kong Chinese population cohort. Endocrinol Diabetes Metab. 2022;5:e340.","journal-title":"Endocrinol Diabetes Metab"},{"key":"6955_CR53","first-page":"425","volume":"14","author":"A Cahyadi","year":"2023","unstructured":"Cahyadi A, Ugrasena IDG, Andarsini MR, Larasati MCS, Jauhari RMZ, Arumsari DK. Relationship between serum ferritin and growth status of pediatric transfusion dependent thalassemia. Casp J Intern Med. 2023;14:425\u201332.","journal-title":"Casp J Intern Med"},{"key":"6955_CR54","doi-asserted-by":"crossref","unstructured":"Pemde H, Jagdish Chandra J, Gupta D, Singh V, Sharma R, Dutta AK. Physical growth in children with transfusion-dependent thalassemia. Ped Health Med Ther. 2011;2.","DOI":"10.2147\/PHMT.S15305"},{"key":"6955_CR55","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ajh.27010","volume":"98","author":"MS Elalfy","year":"2023","unstructured":"Elalfy MS, Hamdy M, Adly A, Ebeid FSE, Temin NT, Rozova A, et al. Efficacy and safety of early-start deferiprone in infants and young children with transfusion-dependent beta thalassemia: Evidence for iron shuttling to transferrin in a randomized, double-blind, placebo-controlled, clinical trial (START). Am J Hematol. 2023;98:1415\u201324.","journal-title":"Am J Hematol"},{"key":"6955_CR56","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1186\/s12891-021-04613-x","volume":"22","author":"X Peng","year":"2021","unstructured":"Peng X, Qu Y, Li X, Liu J, Shan X, Wang J, et al. Bone mineral density and its influencing factors in Chinese children with spinal muscular atrophy types 2 and 3. BMC Musculoskelet Disord. 2021;22:729.","journal-title":"BMC Musculoskelet Disord"},{"key":"6955_CR57","first-page":"68","volume":"4","author":"N Valizadeh","year":"2014","unstructured":"Valizadeh N, Farrokhi F, Alinejad V, Said Mardani S, Valizadeh N, Hejazi S, et al. Bone density in transfusion dependent thalassemia patients in Urmia, Iran. Iran J Ped Hematol Oncol. 2014;4:68\u201371.","journal-title":"Iran J Ped Hematol Oncol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06955-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06955-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06955-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:11:58Z","timestamp":1781842318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06955-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6955"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06955-8","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work has been carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association. The study was approved by the Ethics Committees of Huizhou Central People\u2019s Hospital and Huizhou First Hospital (#ky112022097 and #HZFH2023002), and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"581"}}